Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. (Q54614746)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. |
scientific article |
Statements
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. (English)
Jos W M van der Meer
Heleen D de Koning
Joost Schalkwijk
25 June 2011
128
6
1352-1354